Inogen, Inc. (INGN) fundamentals score
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. It develops, manufactures, ands market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Healthcare · Listed on NASDAQ
Overall: 5.2 out of 10, Mixed fundamentals
- Growth: 4.2/10
- Profitability: 3.7/10
- Financial health: 6.2/10
- Earnings quality: 8.9/10
- Valuation: 4.2/10
Scores are calculated from Inogen, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10